Return On Equity in % of Aptevo Therapeutics Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aptevo Therapeutics Inc. quarterly/annual Return On Equity history and change rate from Q3 2016 to Q3 2025.
  • Aptevo Therapeutics Inc. Return On Equity for the quarter ending 30 Sep 2025 was -389 %, a 11.6% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2024 was -489 %, a 366% decline from 2023.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2023 was -105 %, a 266% decline from 2022.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2022 was 63.1 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Aptevo Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -389 -40.6 -11.6% 01 Jul 2025 30 Sep 2025
Q2 2025 -676 -409 -154% 01 Apr 2025 30 Jun 2025
Q1 2025 -779 -560 -256% 01 Jan 2025 31 Mar 2025
Q4 2024 -489 -384 -366% 01 Oct 2024 31 Dec 2024
Q3 2024 -349 -259 -290% 01 Jul 2024 30 Sep 2024
Q2 2024 -266 -171 -179% 01 Apr 2024 30 Jun 2024
Q1 2024 -219 -312 -337% 01 Jan 2024 31 Mar 2024
Q4 2023 -105 -168 -266% 01 Oct 2023 31 Dec 2023
Q3 2023 -89.5 -164 -219% 01 Jul 2023 30 Sep 2023
Q2 2023 -95.4 -205 -187% 01 Apr 2023 30 Jun 2023
Q1 2023 92.4 +793 01 Jan 2023 31 Mar 2023
Q4 2022 63.1 +409 01 Oct 2022 31 Dec 2022
Q3 2022 75 +317 01 Jul 2022 30 Sep 2022
Q2 2022 110 +379 01 Apr 2022 30 Jun 2022
Q1 2022 -700 -406 -138% 01 Jan 2022 31 Mar 2022
Q4 2021 -346 -179 -108% 01 Oct 2021 31 Dec 2021
Q3 2021 -242 -42.8 -21.5% 01 Jul 2021 30 Sep 2021
Q2 2021 -269 -132 -96% 01 Apr 2021 30 Jun 2021
Q1 2021 -294 -154 -110% 01 Jan 2021 31 Mar 2021
Q4 2020 -167 +0.27 +0.16% 01 Oct 2020 31 Dec 2020
Q3 2020 -199 -38.7 -24.1% 01 Jul 2020 30 Sep 2020
Q2 2020 -137 +11.7 +7.87% 01 Apr 2020 30 Jun 2020
Q1 2020 -140 -17.7 -14.5% 01 Jan 2020 31 Mar 2020
Q4 2019 -167 -58.9 -54.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -161 -82 -104% 01 Jul 2019 30 Sep 2019
Q2 2019 -149 -150 -10065% 01 Apr 2019 30 Jun 2019
Q1 2019 -122 -127 -3016% 01 Jan 2019 31 Mar 2019
Q4 2018 -108 -118 -1205% 01 Oct 2018 31 Dec 2018
Q3 2018 -78.8 -81.6 -2897% 01 Jul 2018 30 Sep 2018
Q2 2018 1.49 +191 01 Apr 2018 30 Jun 2018
Q1 2018 4.2 +165 01 Jan 2018 31 Mar 2018
Q4 2017 9.78 +159 01 Oct 2017 31 Dec 2017
Q3 2017 2.82 +139 01 Jul 2017 30 Sep 2017
Q2 2017 -190 01 Apr 2017 30 Jun 2017
Q1 2017 -160 01 Jan 2017 31 Mar 2017
Q4 2016 -149 01 Oct 2016 31 Dec 2016
Q3 2016 -136 01 Jul 2016 30 Sep 2016

Aptevo Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -489 -384 -366% 01 Jan 2024 31 Dec 2024
2023 -105 -168 -266% 01 Jan 2023 31 Dec 2023
2022 63.1 +409 01 Jan 2022 31 Dec 2022
2021 -346 -179 -108% 01 Jan 2021 31 Dec 2021
2020 -167 +0.27 +0.16% 01 Jan 2020 31 Dec 2020
2019 -167 -58.9 -54.5% 01 Jan 2019 31 Dec 2019
2018 -108 -118 -1205% 01 Jan 2018 31 Dec 2018
2017 9.78 +159 01 Jan 2017 31 Dec 2017
2016 -149 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.